APA (7th ed.) Citation

Z, L., S, I., J, H., B, M., T, M., A, T., . . . MD, G. (2026). Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: A randomized phase II trial. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-26-0469

Chicago Style (17th ed.) Citation

Z, Li, et al. "Gemcitabine Plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 2026. https://doi.org/10.1158/1078-0432.CCR-26-0469.

MLA (9th ed.) Citation

Z, Li, et al. "Gemcitabine Plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 2026, https://doi.org/10.1158/1078-0432.CCR-26-0469.